---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-193510"
form_type: "8-K"
ticker: "IQV"
cik: "0001478242"
company_name: "IQVIA HOLDINGS INC."
filed_at: "2025-09-02T23:59:59+00:00"
generated_at: "2026-05-17T08:50:06.368085+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# IQVIA appoints Michael Fedock as CFO; Ron Bruehlman to retire Feb 28, 2026

## Summary
- Michael Fedock, currently SVP of FP&A, becomes EVP and CFO effective February 28, 2026.
- Ron Bruehlman retires as CFO and transitions to Senior Advisor to the CEO.
- Fedock's base salary rises to $750,000 with annual cash incentive target of 100% of base salary; eligible for LTI grants.
- Fedock has over 25 years in healthcare, including CFO roles at IQVIA Laboratories and R&D Solutions.

## SEC filing metadata
- accession: 0001193125-25-193510
- form_type: 8-K
- ticker: IQV
- cik: 0001478242
- company_name: IQVIA HOLDINGS INC.
- filed_at: 2025-09-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1478242/000119312525193510/0001193125-25-193510-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1478242/000119312525193510/d37930d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-193510
- JSON: https://secwatch.observer/filing/0001193125-25-193510.json
- Plain text: https://secwatch.observer/filing/0001193125-25-193510.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.